ArticleJournal of cardiology cases2026
Effects of Impella support level on coronary blood flow velocity measured by transthoracic Doppler echocardiography.
Article in Journal of cardiology cases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Previous invasive studies on the Impella device (Abiomed, Danvers, MA, USA) have reported that its effect increases coronary artery perfusion. However, non-invasive evaluation using transthoracic Doppler echocardiography (TTDE) remains limited. We assessed the effects of different Impella support levels on coronary blood flow velocity using TTDE in four patients: two with ST-elevation myocardial infarction (STEMI), one with acute myocarditis, and one with myocardial infarction with non-obstructive coronary arteries (MINOCA) due to coronary spasm. The peak diastolic flow velocity (DPV) at the distal left anterior descending artery was measured for a surrogate of coronary blood flow at various Impella flow settings. In STEMI patients, DPV decreased in parallel with stepwise reductions in Impella support levels. In contrast, patients with acute myocarditis and MINOCA exhibited no significant DPV changes despite adjustments in support levels. These findings suggest that the impact of Impella on coronary flow velocity varies according to underlying disease pathology. In STEMI patients post-percutaneous coronary intervention, Impella-induced left ventricular unloading appears to enhance coronary perfusion, while in cases of myocarditis and MINOCA, microvascular dysfunction and other pathophysiological factors may limit this effect. Learning objectives: This non-invasive evaluation used transthoracic Doppler echocardiography to assess the effect of Impella on coronary flow, revealing disease-specific differences. Patients with extensive anterior ST-elevation myocardial infarction showed a support-level-dependent increase in left anterior descending artery flow velocity. In contrast, those with acute myocarditis and myocardial infarction with non-obstructive coronary arteries showed no consistent changes. This suggests the beneficial effect may be dependent on the underlying pathology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.